Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

Traditionally, men who chose radiation therapy for prostate cancer undergo radiation for ... the radiation machine will move and rotate around the target to deliver radiation beams from different ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, ...

Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...

Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of ...